Viamedia, the largest independent cable TV ad management company, issued the following statement regarding the Wednesday, February 22, decision in its antitrust suit against Comcast in the United States District Court for the Northern District of Illinois Eastern Division.
As recognized in the Court’s November 4, 2016 decision, which was unchanged by the Court’s February 22nd decision, Viamedia’s antitrust claims for tying and exclusive dealing are moving ahead because Viamedia has plausibly alleged that Comcast is violating federal and state antitrust and tort laws by forcing competing satellite and cable TV providers to deal directly with Comcast if they want to advertise in regional markets.
Viamedia seeks damages of not less than $75 million, which is subject to trebling under the antitrust statute. Comcast thus faces potential liability in the hundreds of millions of dollars. The Court has ordered that all discovery and dispositive motions be completed by the end of Q3’17.
“We are pleased the Court issued an accelerated schedule to move our antitrust case forward,” said Mark Lieberman, Viamedia president and CEO. “We also understand the US Department of Justice is investigating Comcast’s control and behavior in the spot cable advertising market. Both of these should provide the marketplace protection our industry needs.”
Full Content: PR Newswire
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Top Antitrust Expert Joins Cravath from Paul Weiss
Jan 21, 2025 by
CPI
CMA Chief Removed as UK Government Targets Regulatory Overhaul
Jan 21, 2025 by
CPI
Court Denies Dismissal in Crab Price-Fixing Lawsuit
Jan 21, 2025 by
CPI
TikTok Stays Online for Now: Trump Floats US Ownership Deal
Jan 21, 2025 by
CPI
Hong Kong Watchdog Unveils Compliance Tool for Small Businesses
Jan 21, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Pharmacy Benefit Managers
Jan 20, 2025 by
CPI
Untangling the PBM Mess
Jan 20, 2025 by
Kent Bernard
Using Data, Not Anecdotes, to Analyze Criticisms of Pharmacy Benefit Managers
Jan 20, 2025 by
Dennis Carlton
Vertical Integration and PBMs: What, Me Worry?
Jan 20, 2025 by
Lawton Robert Burns & Bradley Fluegel
The Economics of Benefit Management in Prescription-Drug Markets
Jan 20, 2025 by
Casey B. Mulligan